...drugs that do not provide hallucinogenic effects – and possibly minimize more addictive elements. The new study tested if the psychedelic compound DOI (2,5-dimethoxy-4-iodoamphetamine) could reduce anxiety in mice by...
The California Division of Workers’ Compensation (DWC) adopted long-awaited Pharmaceutical Fee Schedule rules, introducing major changes to pharmaceutical billing and reimbursement. While there are many updates to the new rules,...
...in the workers’ compensation industry have become experts in managing this particular area of concern, these latest numbers remind us that opioid management continues to be more important than ever....
The California Division of Workers' Compensation (DWC) released its annual report on the Independent Medical Review (IMR) program, managed by Maximus Federal Services. IMRs resolve disputes over treatment denials or...
Many clinical trials are underway for drugs to combat COVID-19, but the FDA gave special notice to two drugs. Gilead Sciences initiated two Phase 3 studies of the investigational antiviral...
...Alzheimer’s could interfere with medication adherence, particularly if patients also have a comorbidity. For ongoing coverage of the latest drug approvals and alerts impacting workers’ comp, visit Med Monitor online....
Healthesystems' Advocacy and Compliance team recently attended the NCCI Annual Insights Symposium in Orlando, Florida. This event brings together executive leaders and actuaries from the workers' compensation industry to hear...
...drug would be the first oral antiviral medication for COVID-19. For all of the latest updates on FDA drug approvals impacting workers’ comp, check out our interactive web tool, MedMonitor....
...populations include healthcare workers. Recently, ViiV Healthcare, a GlaxoSmithKline company, communicated to the FDA that several HIV medications they manufacture will be discontinued by the end of 2023. While many...
...for Priority Review the New Drug Application (NDA) for MDMA capsules in combination with psychological intervention for the treatment of PTSD. While this has been long coming, with the FDA...
...framework under the Nebraska Medical Cannabis Patient Protection Act and Regulation Act but would not require the costs of cannabis to be covered by employers, insurance companies or workers’ comp...
...or chewed. Auvelity is expected to hit the market in Q4 of 2022. For ongoing coverage of the latest drug approvals and alerts impacting workers’ comp, visit Med Monitor online....
Explore the latest social media posts from Healthesystems on Facebook, Instagram, LinkedIn, X (Twitter), and Youtube. YouTube Twitter Instagram LinkedIn Facebook...
...is projecting a shortfall of 600,000 home care workers in the next 10 years, according to the California Future Health Workforce Commission. Concurrently, there is increased competition for those direct...
The Workers’ Compensation Research Institute (WCRI) published a new Flash Report on interstate variation and trends in workers’ comp drug payments from Q1 of 2016 to Q1 of 2019. This report presents...
